E72.539
Primary hyperoxaluria, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Primary hyperoxaluria, unspecified, is a rare inherited disorder characterized by the overproduction of oxalate, a natural substance found in many foods. Normally, the body eliminates oxalate through the kidneys in urine. However, in primary hyperoxaluria, the body produces too much oxalate, leading to the formation of calcium oxalate kidney stones and the potential for kidney damage. This condition can affect both kidneys and other organs if not properly managed, making diagnosis and treatment important for maintaining health and preventing complications.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting enzymes responsible for oxalate metabolism. Inherited autosomal recessive trait, meaning both parents must pass the gene for the condition to manifest. Lack of specific enzyme activity, such as alanine-glyoxylate aminotransferase (AGT) in certain types of primary hyperoxaluria. No known environmental or lifestyle factors are directly linked to primary hyperoxaluria; it is primarily a genetic condition.
Key Symptoms: Kidney stones, often recurrent and severe. Pain in the back or side due to kidney stones or obstruction. Hematuria, or blood in the urine. Nausea and vomiting, especially if kidney function declines. Signs of kidney dysfunction or failure, such as swelling in the legs, fatigue, and decreased urine output. In advanced cases, systemic oxalosis where oxalate deposits accumulate in bones, eyes, skin, and other organs, causing pain and functional impairments.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of primary hyperoxaluria involves a combination of clinical evaluation and laboratory testing. Healthcare providers may perform urine tests to measure oxalate levels, blood tests to assess kidney function, and genetic testing to identify specific mutations. Imaging studies, like ultrasound or CT scans, can detect kidney stones or kidney damage. In some cases, a kidney biopsy might be necessary to confirm the diagnosis and determine the extent of tissue damage.
Treatment Protocols: Treatment strategies aim to reduce oxalate production, prevent stone formation, and preserve kidney function. Approaches include:
Clinical Advice & FAQs
Billing Guidance
Is E72.539 a billable ICD-10 code?
Yes, E72.539 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E72.539?
Clinical documentation must specify the nature of Primary hyperoxaluria, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference